{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:50:47Z","timestamp":1790070647710,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bayer PLC"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijcard.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T19:38:46Z","timestamp":1562269126000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study"],"prefix":"10.1016","volume":"299","author":[{"given":"Heba","family":"Nashat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Kempny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Harries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Dormand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Alonso-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gatzoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Wort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.07.004_bb0005","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.105.592386","article-title":"Pulmonary vascular disease in adults with congenital heart disease","volume":"115","author":"Diller","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijcard.2010.02.020","article-title":"Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy","volume":"149","author":"Tay","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0025","doi-asserted-by":"crossref","first-page":"851 e1","DOI":"10.1016\/j.ahj.2005.09.006","article-title":"A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension","volume":"151","author":"Singh","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0030","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/eurheartj\/ehq011","article-title":"Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial","volume":"31","author":"Iversen","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1747-0803.2011.00561.x","article-title":"Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome\u2013a randomized, placebo-controlled, double-blind crossover study","volume":"6","author":"Mukhopadhyay","year":"2011","journal-title":"Congenit. Heart Dis."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.118.033575","article-title":"Evaluation of Macitentan in patients with Eisenmenger syndrome","volume":"139","author":"Gatzoulis","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0045","doi-asserted-by":"crossref","unstructured":"N. Galie, M. Humbert, J. L. Vachiery, S. Gibbs, I. Lang, A. Torbicki, et al., \"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT),\" Eur Heart J, vol. 37, pp. 67\u2013119, Jan 1 2016.","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0050","doi-asserted-by":"crossref","unstructured":"K. A. Nashat H, Price LC, Harries C, Alonso-Gonzalez R, Gatzoulis MA, Wort SJ, Dimopoulos K, \"Eisenmenger syndrome: current perspectives\" Res. Rep. Clin. Cardiol. vol. 8 pp. 1\u201312, 2017.","DOI":"10.2147\/RRCC.S117838"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/eurheartj\/ehv743","article-title":"Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects","volume":"37","author":"Diller","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0060","series-title":"Cardiol Rev, vol. 25, pp. 126\u2013132, May\/Jun","article-title":"Advanced therapy in Eisenmenger syndrome: A systematic review","author":"Hjortshoj","year":"2017"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jjcc.2016.07.002","article-title":"Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome","volume":"69","author":"Chon","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.acvd.2017.01.006","article-title":"Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: a French multicentre study","volume":"110","author":"Hascoet","year":"2017","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.healun.2016.10.006","article-title":"Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome","volume":"36","author":"Hascoet","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study","volume":"127","author":"Gatzoulis","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension","author":"Doran","year":"2008","journal-title":"Int. J. Clin. Pract. Suppl."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0090","doi-asserted-by":"crossref","unstructured":"K. Dimopoulos, G. P. Diller, A. R. Opotowsky, M. D'Alto, H. Gu, G. Giannakoulas, et al., \"Definition and Management of Segmental Pulmonary Hypertension,\" J. Am. Heart Assoc., vol. 7, Jul 4 2018.","DOI":"10.1161\/JAHA.118.008587"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0095","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.112.091421","article-title":"Echocardiographic predictors of outcome in Eisenmenger syndrome","volume":"126","author":"Moceri","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.07.004_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.acvd.2015.11.013","article-title":"Speckle-tracking imaging in patients with Eisenmenger syndrome","volume":"109","author":"Moceri","year":"2016","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/2045893217706691","article-title":"The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension","volume":"7","author":"Gessler","year":"2017","journal-title":"Pulm Circ."},{"key":"10.1016\/j.ijcard.2019.07.004_bb0110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.apmr.2009.02.015","article-title":"Six-minute walk test in patients with down syndrome: validity and reproducibility","volume":"90","author":"Vis","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319314500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319314500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:43:56Z","timestamp":1759092236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319314500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":22,"alternative-id":["S0167527319314500"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.07.004","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}